Laraway Financial Advisors Inc acquired a new stake in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 7,900 shares of the semiconductor company's stock, valued at approximately $3,423,000. Lam Research accounts for about 2.1% of Laraway Financial Advisors Inc's investment portfolio, making the stock its 12th largest holding.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Fideuram Asset Management Ireland dac bought a new position in Lam Research in the fourth quarter worth approximately $10,035,000. Generali Investments Management Co LLC grew its position in shares of Lam Research by 62.0% during the 4th quarter. Generali Investments Management Co LLC now owns 36,274 shares of the semiconductor company's stock valued at $6,209,000 after acquiring an additional 13,878 shares during the period. Rokos Capital Management LLP increased its stake in shares of Lam Research by 42.0% in the 1st quarter. Rokos Capital Management LLP now owns 259,921 shares of the semiconductor company's stock worth $55,532,000 after purchasing an additional 76,840 shares in the last quarter. Aware Super Pty Ltd as trustee of Aware Super purchased a new stake in shares of Lam Research in the 1st quarter worth $59,973,000. Finally, Krilogy Financial LLC raised its holdings in Lam Research by 19.5% in the 1st quarter. Krilogy Financial LLC now owns 28,111 shares of the semiconductor company's stock worth $6,006,000 after purchasing an additional 4,584 shares during the period. Hedge funds and other institutional investors own 84.61% of the company's stock.
Insider Transactions at Lam Research
In other news, Director Eric Brandt sold 54,500 shares of the business's stock in a transaction on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total value of $19,118,600.00. Following the transaction, the director owned 199,205 shares of the company's stock, valued at approximately $69,881,114. The trade was a 21.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Neil J. Fernandes sold 7,659 shares of the company's stock in a transaction on Monday, June 1st. The stock was sold at an average price of $309.60, for a total transaction of $2,371,226.40. Following the transaction, the senior vice president owned 58,470 shares of the company's stock, valued at approximately $18,102,312. This represents a 11.58% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 80,441 shares of company stock valued at $27,614,296. 0.31% of the stock is currently owned by corporate insiders.
Lam Research Stock Performance
NASDAQ:LRCX opened at $332.36 on Monday. The company has a current ratio of 2.63, a quick ratio of 1.91 and a debt-to-equity ratio of 0.30. Lam Research Corporation has a 12-month low of $94.11 and a 12-month high of $438.50. The stock has a 50-day moving average price of $339.46 and a 200 day moving average price of $283.57. The stock has a market capitalization of $415.89 billion, a P/E ratio of 57.70, a P/E/G ratio of 1.32 and a beta of 1.84.
Lam Research (NASDAQ:LRCX - Get Free Report) last issued its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.69 by $0.13. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The company had revenue of $6.72 billion for the quarter, compared to the consensus estimate of $6.66 billion. During the same quarter last year, the company earned $1.33 EPS. The firm's quarterly revenue was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Equities research analysts forecast that Lam Research Corporation will post 9.32 EPS for the current fiscal year.
Lam Research Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 8th. Stockholders of record on Wednesday, June 17th were given a dividend of $0.26 per share. The ex-dividend date was Wednesday, June 17th. This represents a $1.04 annualized dividend and a dividend yield of 0.3%. Lam Research's dividend payout ratio (DPR) is presently 18.06%.
Key Stories Impacting Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Lam Research plans to increase R&D experiment capacity by more than 50% across facilities in the United States, Asia and Europe. Management says the investment should accelerate product development and help customers address increasingly complex AI-chip architectures, materials and nanoscale manufacturing requirements. Reuters article
- Positive Sentiment: Investors are viewing Lam’s expertise in etching, including next-generation atomic-layer etching, as a potentially valuable competitive advantage as AI-driven semiconductor production requires greater manufacturing precision. The company’s recent rebound has renewed optimism that its technology could benefit from a longer-term equipment upcycle. 247WallSt article
- Positive Sentiment: SanDisk’s bullish multiyear financial targets have strengthened expectations for memory-industry capital spending through 2030, supporting demand prospects for semiconductor equipment suppliers such as Lam Research. SanDisk financial targets article
- Neutral Sentiment: Polen Capital identified LRCX as a top performer in its Focus Growth portfolio, while Zacks continues to highlight the stock’s long-term earnings outlook. These endorsements may support sentiment but do not represent new company guidance or guaranteed returns. Polen Capital article
- Negative Sentiment: The R&D expansion requires substantial spending over several years, creating execution and return-on-investment risks. Lam also trades at a relatively elevated valuation after a sharp recovery, leaving the stock vulnerable to profit-taking and concerns that the semiconductor cycle may be approaching a peak.
Analysts Set New Price Targets
Several equities analysts recently weighed in on the company. B. Riley Financial lowered their target price on Lam Research from $385.00 to $350.00 and set a "buy" rating on the stock in a research report on Thursday, July 30th. Deutsche Bank Aktiengesellschaft restated a "buy" rating and issued a $320.00 price target on shares of Lam Research in a research report on Thursday, July 30th. Barclays reaffirmed an "overweight" rating and issued a $335.00 price objective (up from $275.00) on shares of Lam Research in a research note on Thursday, June 11th. Oppenheimer reiterated an "outperform" rating and set a $400.00 price objective (up from $330.00) on shares of Lam Research in a research note on Monday, June 15th. Finally, New Street Research increased their target price on shares of Lam Research from $235.00 to $280.00 and gave the stock a "neutral" rating in a report on Monday, April 27th. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $358.47.
Check Out Our Latest Stock Analysis on LRCX
Lam Research Company Profile
(
Free Report)
Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Read More
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report